#Seroprevalence of human T-lymphotropic virus #HTLV and its associated #factors in #donors of a #blood bank of Medellín – #Colombia, 2014-2018 (PLoS One, abstract)

[Source: PLoS One, full page: (LINK). Abstract, edited.]

OPEN ACCESS /  PEER-REVIEWED / RESEARCH ARTICLE

Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellín-Colombia, 2014-2018

Jaiberth Antonio Cardona-Arias, Carolina Vélez-Quintero , Olga Victoria Calle-González , Jennifer Florez-Duque, Juan Carlos Zapata

Published: August 12, 2019 / DOI: https://doi.org/10.1371/journal.pone.0221060

 

Abstract

Background

Research on HTLV in Colombia is limited; despite being an endemic country there are few studies on the magnitude of this infection. The aim of this study was to determine the seroprevalence of HTLV I/II and its associated factors in donors to a blood bank of Medellín Colombia, 2014–2018.

Methods

This is a cross-sectional study of 52,159 donors with a secondary information source. Seroprevalence of HTLV I/II was determined with its confidence interval and the population characteristics were described by frequency and summary measures. To explore the associated factors, Pearson’s Chi square test, Mann-Whitney U test, crude odds ratios were used and they were adjusted by logistic regression in SPSS 25.0.

Results

88% of the population lived in the metropolitan area, 68.5% belonged to the University. 76.2% were altruistic donors (unpaid donors who did not donate to a specific patient). 24.5% were repetitive (paid) donors. 75% of the donors were under 41 years old. The seroprevalence of HTLV I/II was 0.176% (95% CI = 0.139% -0.213%), being statistically lower in repetitive donors and men.

Conclusion

The seroprevalence of HTLV I/II infection in the studied blood bank is lower than that reported in other blood banks at the departmental and national levels. In Medellín, it was associated with the frequency of donation and gender, which is useful information for the hemovigilance programs of the city.

___

Citation: Cardona-Arias JA, Vélez-Quintero C, Calle-González OV, Florez-Duque J, Zapata JC (2019) Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellín-Colombia, 2014-2018. PLoS ONE 14(8): e0221060. https://doi.org/10.1371/journal.pone.0221060

Editor: Jason Blackard, University of Cincinnati College of Medicine, UNITED STATES

Received: April 11, 2019; Accepted: July 29, 2019; Published: August 12, 2019

Copyright: © 2019 Cardona-Arias et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting Information files.

Funding: This research relies upon salary support for the authors. JAC-A was supported by University of Antioquia and Cooperative University of Colombia. CV-Q, OVC-G, and JF-D were supported, as students, by the University of Antioquia. JCZ salary was supported by the Institute of Human Virology (IHV), University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Keywords: HTLV-I/II; Seroprevalence; Blood safety; Colombia.

——

Advertisements

#Pseudomonas poae–Associated #Fatal #Septic #Transfusion #Reaction, Peoria, #Illinois, #USA, 2017 (Emerg Infect Dis., abstract)

[Source: US Centers for Disease Control and Prevention (CDC), Emerging Infectious Diseases Journal, full page: (LINK). Abstract, edited.]

Volume 25, Number 8—August 2019 / Synopsis

Pseudomonas poae–Associated Fatal Septic Transfusion Reaction, Peoria, Illinois, USA, 2017

Therese S. Woodring and John J. Farrell

Author affiliations: University of Illinois College of Medicine, Peoria, Illinois, USA (T.S. Woodring, J.J. Farrell); OSF System Laboratory, Peoria (J.J. Farrell)

 

Abstract

In the United States, fatal transfusion-transmitted infections from red blood cell units are rare. Although this pattern mostly reflects how inhospitable refrigerated red blood cell units are to contaminant growth, fatalities caused by microorganisms that can grow at storage temperature (4°C), but not in standard clinical blood cultures at 37°C, are probably underestimated. We analyzed a fatal red blood cell transfusion in Peoria, Illinois, USA, that occurred in 2017. Samples from the patient’s whole blood and the red blood cell unit remained culture-negative during the investigation, despite direct visualization of gram-negative bacilli within the unit immediately after transfusion. We identified the bacteria as Pseudomonas poae, a nonpathogenic pseudomonad carrying multiple cold-shock domain protein genes, and confirmed its cold tolerance and inability to grow at 37°C. Our work indicates transfusion reaction workups need to include testing for psychrophilic organisms, which could explain the cause of other apparently culture-negative transfusion reactions.

Keywords: Blood safety; Pseudomonas poae; USA; Illinois.

——

#Seroreactivity to #Chikungunya and #WNV Viruses in #Rwandan #Blood Donors (Vector Borne Zoo Dis., abstract)

[Source: Vector Borne and Zoonotic Diseases, full page: (LINK). Abstract, edited.]

Seroreactivity to Chikungunya and West Nile Viruses in Rwandan Blood Donors

Eric Seruyange, Karl Ljungberg, Claude Mambo Muvunyi, Jean Bosco Gahutu, Swaibu Katare, José Nyamusore, Yong-Dae Gwon, Magnus Evander, Heléne Norder, Peter Liljeström, and Tomas Bergström

Published Online: 27 Jun 2019

 

Abstract

Introduction:

Chikungunya virus (CHIKV) and West Nile virus (WNV) have previously been reported from several African countries, including those bordering Rwanda where they may have originated. However, there have been no serosurveillance reports from Rwanda regarding these two viral pathogens.

In this article, we present the first study of immunoglobulin G (IgG) seroreactivity of CHIKV and WNV in Rwandan blood donor samples.

Methods:

Blood donors from Rwanda (n = 874) and Sweden (n = 199) were tested for IgG reactivity against CHIKV, using an in-house enzyme-linked immunosorbent assay with the E1 envelope protein fused with p62 as antigen, and against WNV using a commercial kit. Data on mosquito distribution were obtained from the 2012 assessment of yellow fever virus circulation in Rwanda.

Results:

Seroreactivity to CHIKV was high in Rwanda (63.0%), when compared with Swedish donors, where only 8.5% were IgG positive. However, a cross-reactivity to O’nyong’nyong virus in neutralization test was noted in Rwandan donors. No significant difference in WNV seroreactivity was found (10.4% for Rwandan and 14.1% for Swedish donors). The relatively high seroreactivity to WNV among Swedish donors could partly be explained by cross-reactivity with tick-borne encephalitis virus prevalent in Sweden. Donors from the Eastern Province of Rwanda had the highest IgG reactivity to the two investigated viruses (86.7% for CHIKV and 33.3% for WNV). Five genera of mosquitoes were found in Rwanda where Culex was the most common (82.5%). The vector of CHIKV, Aedes, accounted for 9.6% of mosquitoes and this species was most commonly found in the Eastern Province.

Conclusions:

Our results showed high seroreactivity to CHIKV in Rwandan donors. The highest IgG reactivity to CHIKV, and to WNV, was found in the Eastern Province, the area reporting the highest number of mosquito vectors for these two viruses. Infection control by eliminating mosquito-breeding sites in population-dense areas is recommended, especially in eastern Rwanda.

Keywords: Arbovirus; Chikungunya virus; WNV; Serology; Seroprevalence; Rwanda.

—–

#WNV #Seroprevalence Among #Blood #Donors in #Hungary (Vector Borne Zoo Dis., abstract)

[Source: Vector Borne and Zoonotic Diseases, full page: (LINK). Abstract, edited.]

West Nile Virus Seroprevalence Among Blood Donors in Hungary

Anna Nagy, Tímea Szöllősi, Mária Takács, Nóra Magyar, and Éva Barabás

Published Online: 11 Jun 2019 / DOI: https://doi.org/10.1089/vbz.2018.2401

 

Abstract

Background and Objectives:

West Nile virus (WNV) is one of the most important viral zoonotic infections in Hungary; however, no transfusion-transmitted WNV infections have been confirmed so far. In 2016, the number of clinical cases of WNV reported was 44, but the seasonal WNV screening of whole-blood donors has not yet been implemented. Our aims were to assess the WNV RNA reactivity and the prevalence of WNV-specific antibodies in the samples of blood donors collected in 2016.

Materials and Methods:

WNV RNA with Cobas TaqScreen and anti-WNV antibody determination from plasma samples of 2112 donors was performed. Cross-reactivity to tick-borne encephalitis virus was excluded. WNV neutralization test was used for the confirmation of anti-WNV IgG reactive results, and the presence of anti-WNV IgM antibodies was also determined.

Results:

None of the samples showed WNV RNA reactivity. The total weighted anti-WNV IgG prevalence was 2.34% (95% confidence interval 1.65–3.03), and in addition, three donors were found to be IgM positive. There was a comparable tendency between the data of WNV seroprevalence and cumulative incidence in six out of seven statistical regions in Hungary.

Conclusion:

Our results show a comparable data with publications that estimated the WNV seroprevalence in some other European endemic areas. As protective measures, both the 30-day deferral of blood donors who spent at least 24 h in WNV-exposed areas and the exclusion of affected Hungarian territories from blood donation are enforced by the Hungarian National Blood Transfusion Service. Our study is the first comprehensive serological survey to obtain actual data about WNV seroprevalence in the Hungarian human population.

Keywords: WNV; Serology; Seroprevalence; Blood safety; Hungary.

——

#WNV and #Usutu Virus #Infections and Challenges to #Blood #Safety in the #EU (Emerg Infect Dis., abstract)

[Source: US Centers for Disease Control and Prevention (CDC), Emerging Infectious Diseases Journal, full page: (LINK). Abstract, edited.]

Volume 25, Number 6—June 2019 / Perspective

West Nile and Usutu Virus Infections and Challenges to Blood Safety in the European Union

Dragoslav Domanović  , Celine M. Gossner, Ryanne Lieshout-Krikke, Wolfgang Mayr, Klara Baroti-Toth, Alina Mirella Dobrota, Maria Antonia Escoval, Olaf Henseler, Christof Jungbauer, Giancarlo Liumbruno, Salvador Oyonarte, Constantina Politis, Imad Sandid, Miljana Stojić Vidović, Johanna J. Young, Inês Ushiro-Lumb, and Norbert Nowotny

Author affiliations: European Centre for Disease Prevention and Control, Solna, Sweden (D. Domanović, C.M. Gossner, J.J. Young); European Blood Alliance, Amsterdam, the Netherlands (R. Lieshout-Krikke); Austrian Red Cross, Vienna, Austria (W. Mayr, C. Jungbauer); National Competent Authority for Blood, Budapest, Hungary (K. Baroti-Toth); National Competent Authority for Blood, Bucharest, Romania (A.M. Dobrota); National Competent Authority for Blood, Lisbon, Portugal (M.A. Escoval); Paul Ehrlich Institute, Langen, Germany (O. Henseler); Italian National Blood Centre, National Institute of Health, Rome, Italy (G. Liumbruno); National Competent Authority for Blood, Madrid, Spain (S. Oyonarte); Hellenic Center for Disease Control and Prevention (KEELPNO), Athens, Greece (C. Politis); National Competent Authority for Blood, Paris, France (I. Sandid); Croatian Institute for Transfusion Medicine, Zagreb, Croatia (M.S. Vidović); National Health Service Blood and Transplant (NHSBT), London, UK (I. Ushiro-Lumb); University of Veterinary Medicine, Vienna, Austria (N. Nowotny); Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates (N. Nowotny)

 

Abstract

West Nile virus (WNV) and Usutu virus (USUV) circulate in several European Union (EU) countries. The risk of transfusion-transmitted West Nile virus (TT-WNV) has been recognized, and preventive blood safety measures have been implemented. We summarized the applied interventions in the EU countries and assessed the safety of the blood supply by compiling data on WNV positivity among blood donors and on reported TT-WNV cases. The paucity of reported TT-WNV infections and the screening results suggest that blood safety interventions are effective. However, limited circulation of WNV in the EU and presumed underrecognition or underreporting of TT-WNV cases contribute to the present situation. Because of cross-reactivity between genetically related flaviviruses in the automated nucleic acid test systems, USUV-positive blood donations are found during routine WNV screening. The clinical relevance of USUV infection in humans and the risk of USUV to blood safety are unknown.

Keywords: Usutu virus; WNV; Blood safety; EU.

——

Expanding #Usutu virus #circulation in #Italy: detection in the Lazio region, central Italy, 2017 to 2018 (Euro Surveill., abstract)

[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]

Expanding Usutu virus circulation in Italy: detection in the Lazio region, central Italy, 2017 to 2018

Fabrizio Carletti1, Francesca Colavita1, Francesca Rovida2, Elena Percivalle2, Fausto Baldanti2,3, Ida Ricci4, Claudio De Liberato4, Francesca Rosone4, Francesco Messina1, Eleonora Lalle1, Licia Bordi1, Francesco Vairo5, Maria Rosaria Capobianchi1, Giuseppe Ippolito6, Giuseppina Cappiello7, Alberto Spanò7, Silvia Meschi1, Concetta Castilletti1

Affiliations: 1 Laboratory of Virology, National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ IRCCS, Rome, Italy; 2 Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3 Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy; 4 Istituto Zooprofilattico Sperimentale delle regioni Lazio e Toscana, Rome, Italy; 5 Regional Service for Surveillance and Control of Infectious Diseases (SERESMI)-Lazio Region, National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ IRCCS, Rome, Italy; 6 Scientific Direction, National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ IRCCS, Rome, Italy; 7 Unit of Microbiology, Sandro Pertini Hospital, Rome, Italy

Correspondence: Silvia Meschisilvia.meschiinmi.it

Citation style for this article: Carletti Fabrizio, Colavita Francesca, Rovida Francesca, Percivalle Elena, Baldanti Fausto, Ricci Ida, De Liberato Claudio, Rosone Francesca, Messina Francesco, Lalle Eleonora, Bordi Licia, Vairo Francesco, Capobianchi Maria Rosaria, Ippolito Giuseppe, Cappiello Giuseppina, Spanò Alberto, Meschi Silvia, Castilletti Concetta. Expanding Usutu virus circulation in Italy: detection in the Lazio region, central Italy, 2017 to 2018. Euro Surveill. 2019;24(3):pii=1800649. https://doi.org/10.2807/1560-7917.ES.2019.24.3.1800649

Received: 03 Dec 2018;   Accepted: 16 Jan 2019

 

Abstract

Blood donation screening for West Nile virus (WNV) was mandatory in the Lazio region in 2017 and 2018 (June-November) according to the national surveillance plan. In these years, all five donations reactive in WNV nucleic acid amplification tests harboured instead Usutu virus (USUV). Clade ‘Europe 2’ was identified in four blood donations and a 2018 mosquito pool. The cocirculation of WNV and USUV in Lazio warrants increased laboratory support and awareness of possible virus misidentification.

©  This work is licensed under a Creative Commons Attribution 4.0 International License.

Keywords: Arbovirus; Usutu Virus; WNV; Italy.

——

#Seroprevalence of #Dengue and #Zika Virus in #Blood #Donations: A Systematic Review (Transfus Med Rev., abstract)

[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]

Transfus Med Rev. 2018 Oct 31. pii: S0887-7963(18)30094-4. doi: 10.1016/j.tmrv.2018.10.001. [Epub ahead of print]

Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic Review.

Eick SM1, Dale AP2, McKay B3, Lawrence C4, Ebell MH5, Cordero JF6, Welton M7.

Author information: 1 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: eick.steph@gmail.com. 2 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: aperrydale@gmail.com. 3 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: bmckay81@gmail.com. 4 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: crl99301@uga.edu. 5 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: ebell@uga.edu. 6 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: jcordero@uga.edu. 7 Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, University of Georgia Health Sciences Campus, Athens, GA. Electronic address: Michael.welton@gmail.com.

 

Abstract

The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82% for DENV and 0.53% for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings.

KEYWORDS: Blood donations; Blood supply; Dengue virus; Surveillance; Transmission; Zika virus

PMID: 30471867 DOI: 10.1016/j.tmrv.2018.10.001

Keywords: Zika Virus; Dengue Fever; Blood Safety; Seroprevalence.

——